Recent News & Comments About total parenteral nutrition
NPS Pharmaceuticals Reports First Quarter 2012 Financial Results
NPS Pharmaceuticals, Inc. , a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported its re
NPS first quarter net loss increases to $10.6 million
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the first quarter of 2012.
Lumberton teenager fueled by challenge of rare disease
LUMBERTON — Amidst the sound of boxes being unpacked, Darlene Gold answers the knock at the door of her Lumberton home and apologizes for the mess. She explains that her daughter, Catherine, is ju...
Potion in motion
Virgin coconut oil has been getting a bad rap for a long time but perceptions are now changing as new research paints it in a positive light.
Hospital, CHW settle $3.5 million malpractice case
Catholic Healthcare West, doing business as Mark Twain St. Joseph’s Hospital, and medical professionals agreed to pay a $3.5 million malpractice settlement approved at a court hearing Tuesday, and hospital officials are refusing to discuss the case.
Dream Space
‘Wow’ bedroom a gift to kids with life-threatening illnesses
Press Release
NPS Pharmaceuticals Inc. Posted on:04 May 12 NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the first quarter of 2012.
 |
|
Diet Sponsors
Free Diet Articles
|
